Vipin Agarwal

Dr. Vipin Agarwal is the President and CEO at NorthEast BioLab. He has extensive experience managing bioanalytical laboratories in the biotechnology industry under GLP/GCP environments.

He has excellent knowledge of state-of-the-art instrumentation (Mass Spectrometry, HPLC, automation in sample preparation, Etc.) and a profound understanding of the role of bioanalyses in the drug development process from discovery to market.

Dr. Agarwal demonstrates comprehensive knowledge of the FDA’s drug development requirements, including submitting Investigational New Drug (IND) and New Drug Application (NDA). Prior to Founding NorthEast BioLab in 2003, Dr. Agarwal was Deputy Director of Bioanalytics at Bayer Pharmaceuticals.

He has a PhD from the University of New Brunswick in Canada and an MBA from Rensselaer Polytechnic Institute in Troy, NY. Notably, Dr. Agarwal actively contributes as a member of prestigious organizations, such as the Journal of Liquid Chromatography & Related Technologies and the American Chemical Society.